Syntocinon 40 IE/ml neusspray clinical trials

Effects of intranasal oxytocin in the treatment of benzodiazepine withdrawal: A pilot randomized parallel group placebo-controlled trial

This study is looking into whether a nasal spray containing oxytocin can help people reduce their dependence on benzodiazepine medication more effectively than current methods. They're comparing it to regular dose reduction and a dummy spray, focusing on easing withdrawal symptoms.